Emergent BioSolutions Inc.
LSE: 0IGA.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Joseph C. Papa Jr.
- Employees
- 900
- Headquarters
- Gaithersburg, United States
- IPO year
- 2018
- Market cap
- $502.3M
- Website
- https://www.emergentbiosolutions.com
Loading 0IGA…
Loading profile data…Frequently asked questions about 0IGA
What does Emergent BioSolutions Inc. (0IGA.L) do?
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
Where does 0IGA.L trade?
Emergent BioSolutions Inc. (0IGA.L) trades on the London Stock Exchange.
What sector is 0IGA.L in?
Emergent BioSolutions Inc. (0IGA.L) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Emergent BioSolutions Inc.?
Joseph C. Papa Jr. is the chief executive officer of Emergent BioSolutions Inc. (0IGA.L).
Where is Emergent BioSolutions Inc. headquartered?
Emergent BioSolutions Inc. is headquartered in United States.
Does 0IGA.L pay a dividend?
Emergent BioSolutions Inc. (0IGA.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0IGA.L go public?
Emergent BioSolutions Inc. (0IGA.L) completed its initial public offering in 2018.